000 01708 a2200481 4500
005 20250516114035.0
264 0 _c20130516
008 201305s 0 0 eng d
022 _a1756-2651
024 7 _a10.1093/jb/mvs112
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTanaka, Kyoko
245 0 0 _aPossible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells.
_h[electronic resource]
260 _bJournal of biochemistry
_cDec 2012
300 _a587-94 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aCarcinoma
_xdrug therapy
650 0 4 _aCell Line, Tumor
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCholesterol
_xmetabolism
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aGlycolipids
_xmetabolism
650 0 4 _aGlycosyltransferases
_xgenetics
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aMultidrug Resistance-Associated Proteins
_xgenetics
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aPhospholipids
_xmetabolism
650 0 4 _aSialyltransferases
_xmetabolism
700 1 _aTakada, Hidetaka
700 1 _aIsonishi, Seiji
700 1 _aAoki, Daisuke
700 1 _aMikami, Mikio
700 1 _aKiguchi, Kazushige
700 1 _aIwamori, Masao
773 0 _tJournal of biochemistry
_gvol. 152
_gno. 6
_gp. 587-94
856 4 0 _uhttps://doi.org/10.1093/jb/mvs112
_zAvailable from publisher's website
999 _c22160498
_d22160498